Understanding cardiac troponin part 1: avoiding troponinitis
Richard Body1,2,3, Edward Carlton4
1Cardiovascular Sciences Research Group, The University of Manchester, Manchester, UK.
Emergency Medicine Journal : EMJ
|August 9, 2017
Summary
Elevated cardiac troponin (cTn) indicates myocardial injury but not always acute myocardial infarction (AMI). Clinicians must consider clinical context, patient baseline, and serial cTn trends to accurately diagnose AMI and avoid misdiagnosis.
Area of Science:
- Cardiology
- Biomarkers
- Diagnostic Medicine
Background:
- Cardiac troponin (cTn) is a specific biomarker for myocardial injury.
- Elevated cTn is crucial for diagnosing acute myocardial infarction (AMI).
- However, elevated cTn alone does not confirm AMI, leading to potential misdiagnosis ('troponinitis').
Purpose of the Study:
- To provide a structured overview for clinicians on interpreting positive cTn results.
- To differentiate AMI from other causes of myocardial injury.
- To prevent underdiagnosis and overdiagnosis of AMI.
Main Methods:
- Review of clinical context for differentiating Type 1 (coronary artery disease) vs. Type 2 (demand-supply imbalance) AMI.
- Assessment of patient baseline factors for chronic cTn elevation.
- Utilizing serial cTn sampling to detect acute changes.
Main Results:
- Clinical context is essential to distinguish primary AMI from secondary myocardial injury.
- Patient's baseline and historical cTn levels help identify chronic elevations.
- Serial cTn measurements reveal expected dynamic changes in acute myocardial injury.
Conclusions:
- Accurate interpretation of cTn requires considering clinical context, baseline, and serial trends.
- This approach helps avoid misclassifying myocardial injury as AMI.
- Proper interpretation of cTn results is key to appropriate AMI diagnosis and management.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
973
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
973
01:30Acute Coronary Syndrome III: Diagnostic Studies
321
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
321
01:30Acute Coronary Syndrome I: Introduction
1.2K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.2K
01:14Myocarditis III: Medical Management
251
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
251
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
633
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
633
01:22Myocarditis IV: Nursing Management
286
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
286